People with diabetes or fatty liver disease are less effective at obtaining energy from ketone bodies

The liver plays a central role in storing and supplying energy to the body. In type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD, commonly referred to as fatty liver disease), mitochondria—the cell’s power plants—cannot switch efficiently between fuel sources. Scientists at the DZD partner German Diabetes Center (DDZ), Heinrich-Heine-University Düsseldorf (HHU) and the University Hospital Düsseldorf (UKD) measured, for the first time, how well mitochondria in heart, muscle, liver, and kidney can use the breakdown products of fats – ketone bodies – to produce energy. Ketone body levels can be increased through fasting, exercise, or low-carbohydrate diets. The study shows that energy generation via ketone body metabolism is reduced in insulin resistance such as in type 2 diabetes and MASLD, highlighting a potential new target for improving energy metabolism in diabetes.

Our bodies rely on the ability to switch between different energy sources depending on nutrient availability. Ketone bodies are small molecules made by the liver from fatty acids when glucose is scarce. They provide an alternative fuel for the heart, skeletal muscle, the kidney, and several other organs. An increased ketone level can support energy production in healthy individuals, but their benefit in this context depends on the mitochondria’s ability to utilize them. “Ketone bodies are more than just an alternative fuel in specific conditions — they serve as important fuels for all domains of life to produce energy. In our study, we investigated if mitochondria in people with diabetes or fatty liver disease can still use them effectively,” says Professor Michael Roden, Scientific Director and Spokesperson for the Board of the DDZ and Director of the Department of Endocrinology and Diabetology at Düsseldorf University Hospital.

Simply increasing ketone levels may not be enough for people with type 2 diabetes

The researchers examined numerous tissue samples from obese people with and without type 2 diabetes or with and without MASLD. Using a novel approach based on a technique called high-resolution respirometry, the researchers were able, for the first time, to directly measure mitochondrial energy production from ketone bodies. “Previous studies only looked at ketone body levels in the blood or organs, but our novel approach reveals the actual ketone body-driven energy output by mitochondria in the context of their cellular environment, offering a more representative view of metabolic alterations – even though it can only capture metabolism ex-vivo, not within the living organism”, explains Dr. Cesare Granata, senior author, and Research Associate at the DDZ. In this collaborative research effort, participants and data were acquired from different ongoing studies at the DDZ and the UKD, like the BARIA-DDZ study, the German Diabetes Study (GDS), and the METAB-HTx study.

Why ketone body metabolism is particularly vulnerable in insulin resistance

The results were clear: in all the insulin-resistant states investigated, mitochondria produce less energy from ketone bodies. Compared to the respective control groups, heart and skeletal muscle cells of overweight individuals with type 2 diabetes and liver cells of overweight individuals with MASLD showed poorer utilization of ketone bodies for energy production. “Interestingly, this defect was greater than the overall decline in mitochondrial function, suggesting that ketone body metabolism is particularly vulnerable in insulin resistance,” says Dr. Elric Zweck, lead author and Guest Researcher at the DDZ and Research Group Leader at the Department of Cardiology, Pulmonology and Vascular Medicine at UKD and HHU. 

These findings may have direct implications for people with diabetes, suggesting that simply increasing ketone body levels may not be sufficient to improve energy production, if mitochondria cannot use them efficaciously. Future treatments should be aimed at improving mitochondrial ketone body utilization and restore metabolic flexibility. Follow-up studies of the study group will further explore the mechanisms behind this altered ketone body metabolism and identify possible therapies.

Original publication:
Zweck, E., Piel, S., Schmidt, J. W. et al. Impaired mitochondrial ketone body oxidation in insulin resistant states. EBioMedicine (2025). Doi:https://doi.org/10.1016/j.ebiom.2025.106007 

Media contact:
German Diabetes Center
PR
Susan Jörges
Auf'm Hennekamp 65
40225 Düsseldorf
Phone +49 (0)211 3382-450
pressestelle@ddz.de

The German Diabetes Center (DDZ) serves as the German reference center for diabetes. Its objective is to contribute to the improvement of prevention, early detection, diagnosis and treatment of diabetes mellitus. At the same time, the research center aims at improving the epidemiological data situation in Germany. The DDZ coordinates the multicenter German Diabetes Study and is a point of contact for all players in the health sector. In addition, it prepares scientific information on diabetes mellitus and makes it available to the public. The DDZ is part of the Leibniz Association (Wissenschaftsgemeinschaft Gottfried Wilhelm Leibniz, WGL) and is a partner of the German Center for Diabetes Research (DZD e.V.). www.ddz.de/en 

The German Center for Diabetes Research (DZD) is a national association that brings together experts in the field of diabetes research and combines basic research, translational research, epidemiology and clinical applications. The aim is to develop novel strategies for personalized prevention and treatment of diabetes. Members are Helmholtz Munich – German Research Center for Environmental Health, the German Diabetes Center in Düsseldorf, the German Institute of Human Nutrition in Potsdam-Rehbrücke, the Paul Langerhans Institute Dresden of Helmholtz Munich at the University Medical Center Carl Gustav Carus of the TU Dresden and the Institute for Diabetes Research and Metabolic Diseases of Helmholtz Munich at the Eberhard-Karls-University of Tuebingen together with associated partners at the Universities in Heidelberg, Cologne, Leipzig, Lübeck and Munich. www.dzd-ev.de/en